Glycaemic and blood pressure controls achieved in a cohort of 318 patients with type 2 diabetes

Acta Clinica Belgica

Volumn 54, Issue 6, 1999, Pages 328-333

  Buysschaert, M ^a   Hermans, M P ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Complications; Glycaemia; Hypertension; Treatment; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; METFORMIN;

ADULT; AGED; ARTICLE; BELGIUM; BLOOD PRESSURE REGULATION; CHRONIC DISEASE; COHORT ANALYSIS; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYNEUROPATHY; PREVALENCE; RETINOPATHY; VASCULAR DISEASE;

EID: 0033381811     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.1999.11754256     Document Type: Article

References (15)

1. Buysschaert M. In: Diabétologie clinique. De Boeck Université, Louvain-la-Neuve, Paris, 1998, pp 27-35.
2. Haffner S, Lehto S, Ronneman T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339: 229-34.
3. Haffner S. The importance of hyperglycaemia in the nonfasting state to the development of cardiovascular disease. Endocrine Reviews. 1998; 19(5); 583-92.
4. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-57.
5. United Kingdom Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J. 1998; 317: 703-13.
6. The Expert Committee on the diagnosis and complications of diabetes mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997; 20: 1183-97.
7. Paris I, Hermans MP, Buysschaert M. Glycaemic control in type 1 diabetes: a cross-sectional study in 1200 Belgian patients. Diabetes Care (Letter). 1998; 21:2200-1.
8. Buysschaert M, Maes M, Hermans MP. Traitement et contrôle glycémique de 1200 diabétiques inscrits dans les Conventions INAMI «Diabète». Acta Clin Belg. 1997; 52: 211-8.
9. United Kingdom Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998; 352: 854-65.
10. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995; 28: 103-17.
11. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med. 1993; 329: 977-86.
12. Turner RC, Millins H, Straton IM, Manly SE, Matthews DR, Holman RR for the United Kingdom Prospective Diabetes Study Group. Risk factors for coronary artery disease in non insulin-dependent diabetes mellitus. Br Med J. 1998; 316: 823-8.
13. Bouillon R. Buysschaert M. Le traitement de l'hypertension artérielle chez le diabétique. Louvain Méd. 1995; 114: 73-7.
14. Bruno G, Merletti F, Boffetta P. Cavalo-Perin P, Bargero G, Gallone G. Pagano G. Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an italian population-based cohort of type II (non insulin-dependent) diabetes mellitus. Diabetologia. 1999; 42: 297-301.
15. Estacio R, Jeffers B, Hiatt W, Biggerstaff S, Gifford N, Schrier R. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non insulin-dependent diabetes and hypertension. N Engl J Med. 1998; 338: 645-52.